-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Feb 12, 11:20Prev. Close
1498.10
Open Price
1490.00
Bid Price (Qty.)
1474.80 (31)
Offer Price (Qty.)
1477.50 (11)
NSE Live
Feb 12, 11:20Prev. Close
1498.80
Open Price
1491.50
Bid Price (Qty.)
1475.70 (2)
Offer Price (Qty.)
1476.00 (16)
| Cash Flow of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 219.33 | 201.35 | 108.14 | 135.57 | |
| Net CashFlow From Operating Activities | 280.97 | 287.87 | 52.89 | 217.21 | |
| Net Cash Used In Investing Activities | -119.53 | -213.05 | -142.63 | -134.65 | |
| Net Cash Used From Financing Activities | -193.37 | -23.25 | 81.20 | -74.11 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -31.93 | 51.57 | -8.54 | 8.45 | |
| Cash And Cash Equivalents Begin of Year | 60.68 | 7.48 | 16.91 | 8.47 | |
| Cash And Cash Equivalents End Of Year | 28.75 | 59.05 | 8.37 | 16.91 |
10.02.2026
Emcure Pharmace Consolidated December 2025 Net Sales at Rs 2,363.48 crore, up 20.42% Y-o-Y
09.02.2026
Emcure Pharmace Standalone December 2025 Net Sales at Rs 1,418.31 crore, up 37.86% Y-o-Y
09.02.2026
09.01.2026
10.02.2026
Emcure Pharmace Consolidated December 2025 Net Sales at Rs 2,363.48 crore, up 20.42% Y-o-Y
09.02.2026
Emcure Pharmace Standalone December 2025 Net Sales at Rs 1,418.31 crore, up 37.86% Y-o-Y
17.11.2025
Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y
12.11.2025
Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y
